print PRINT

SCIENCE > Health

Japan still unable to produce its own COVID-19 vaccine 

  • January 6, 2021
  • , Asahi
  • JMH Summary

Asahi wrote that the nation’s pharmaceutical industry has not yet been able to roll out a vaccine for the novel coronavirus even though their foreign counterparts have already begun shipping their products for vaccination. Although two Japanese drug firms have started clinical trials, they have not yet disclosed when their products will be ready for use. While pointing out that the GOJ has pledged some 300 billion yen ($2.9 billion) in financial assistance for COVID-19 vaccine development and production, the daily said that even before the coronavirus pandemic few Japanese drug companies were interested in vaccine development and production because the domestic market is small and leading American and European pharmaceutical manufacturers such as Pfizer and AstraZeneca are dominant forces in the international market.  

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan